A Study to Evaluate the Safety, Tolerability, and Efficacy of Odanacatib (MK-0822) in Postmenopausal Women Previously Treated With a Bisphosphonate (MK-0822-042)
Clinical trial NCT00885170 · COMPLETED
Trial details
- NCT number
- NCT00885170
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-04-13
- Primary completion
- 2011-09-15
- Enrollment
- 246
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.